US Stock MarketDetailed Quotes

Kezar Life Sciences (KZR)

Watchlist
  • 7.330
  • +0.060+0.83%
Close Apr 24 16:00 ET
  • 7.330
  • 0.0000.00%
Post 16:00 ET
54.03MMarket Cap-0.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kezar Life Sciences (KZR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.36%52.27M
-61.40%8.33M
-46.62%11.72M
-33.34%14.6M
-25.65%17.63M
-20.58%89.14M
-24.04%21.58M
-32.52%21.95M
-18.23%21.9M
-3.32%23.71M
Selling and administrative expenses
-20.86%18.51M
-41.42%3.25M
-15.86%4.8M
-10.48%5.02M
-16.67%5.45M
-11.86%23.39M
-3.73%5.55M
-35.08%5.71M
-3.15%5.6M
5.37%6.54M
-General and administrative expense
-20.86%18.51M
-41.42%3.25M
-15.86%4.8M
-10.48%5.02M
-16.67%5.45M
-11.86%23.39M
-3.73%5.55M
-35.08%5.71M
-3.15%5.6M
5.37%6.54M
Research and development costs
-48.65%33.76M
-68.32%5.08M
-57.43%6.91M
-41.20%9.58M
-29.07%12.18M
-23.29%65.74M
-29.20%16.03M
-31.58%16.24M
-22.39%16.3M
-6.26%17.17M
Operating profit
41.36%-52.27M
61.40%-8.33M
46.62%-11.72M
33.34%-14.6M
25.65%-17.63M
15.30%-89.14M
24.04%-21.58M
14.02%-21.95M
18.23%-21.9M
3.32%-23.71M
Net non-operating interest income expense
-55.25%3.07M
-54.05%618K
-70.15%488K
-51.25%895K
-47.74%1.07M
-28.10%6.87M
-42.25%1.35M
-32.55%1.64M
-25.85%1.84M
-11.70%2.05M
Non-operating interest income
-47.48%4.44M
-53.81%801K
-49.66%1.03M
-46.49%1.2M
-42.11%1.42M
-23.79%8.46M
-36.44%1.73M
-27.73%2.04M
-21.81%2.24M
-8.98%2.45M
Non-operating interest expense
-14.00%1.37M
-52.96%183K
33.50%538K
-24.69%302K
-13.25%347K
2.77%1.59M
-2.51%389K
1.77%403K
4.16%401K
8.11%400K
Other net income (expense)
-365.10%-6.84M
76.24%-1.47M
12K
-1.48M
Special income (charges)
-365.10%-6.84M
-57,075.00%-6.84M
--0
--0
----
76.24%-1.47M
100.19%12K
--0
---1.48M
----
-Less：Restructuring and merger&acquisition
7,367.09%5.74M
467.78%5.74M
--0
--0
----
-102.41%-79K
-147.61%-1.56M
--0
--1.48M
----
-Write off
-29.24%1.1M
----
----
----
----
-46.73%1.55M
----
----
----
----
Income before tax
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Income tax
Net income
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Net income continuous Operations
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Minority interest income
Net income attributable to the parent company
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.08%-56.03M
28.05%-14.55M
44.73%-11.23M
36.40%-13.7M
23.56%-16.56M
17.80%-83.74M
37.33%-20.22M
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
Basic earnings per share
33.33%-7.66
33.67%-1.99
44.96%-1.53
36.82%-1.87
23.83%-2.27
18.16%-11.49
32.43%-3
12.58%-2.78
12.94%-2.96
3.87%-2.98
Diluted earnings per share
33.33%-7.66
33.67%-1.99
44.96%-1.53
36.82%-1.87
23.83%-2.27
18.16%-11.49
32.43%-3
12.58%-2.78
12.94%-2.96
3.87%-2.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -41.36%52.27M-61.40%8.33M-46.62%11.72M-33.34%14.6M-25.65%17.63M-20.58%89.14M-24.04%21.58M-32.52%21.95M-18.23%21.9M-3.32%23.71M
Selling and administrative expenses -20.86%18.51M-41.42%3.25M-15.86%4.8M-10.48%5.02M-16.67%5.45M-11.86%23.39M-3.73%5.55M-35.08%5.71M-3.15%5.6M5.37%6.54M
-General and administrative expense -20.86%18.51M-41.42%3.25M-15.86%4.8M-10.48%5.02M-16.67%5.45M-11.86%23.39M-3.73%5.55M-35.08%5.71M-3.15%5.6M5.37%6.54M
Research and development costs -48.65%33.76M-68.32%5.08M-57.43%6.91M-41.20%9.58M-29.07%12.18M-23.29%65.74M-29.20%16.03M-31.58%16.24M-22.39%16.3M-6.26%17.17M
Operating profit 41.36%-52.27M61.40%-8.33M46.62%-11.72M33.34%-14.6M25.65%-17.63M15.30%-89.14M24.04%-21.58M14.02%-21.95M18.23%-21.9M3.32%-23.71M
Net non-operating interest income expense -55.25%3.07M-54.05%618K-70.15%488K-51.25%895K-47.74%1.07M-28.10%6.87M-42.25%1.35M-32.55%1.64M-25.85%1.84M-11.70%2.05M
Non-operating interest income -47.48%4.44M-53.81%801K-49.66%1.03M-46.49%1.2M-42.11%1.42M-23.79%8.46M-36.44%1.73M-27.73%2.04M-21.81%2.24M-8.98%2.45M
Non-operating interest expense -14.00%1.37M-52.96%183K33.50%538K-24.69%302K-13.25%347K2.77%1.59M-2.51%389K1.77%403K4.16%401K8.11%400K
Other net income (expense) -365.10%-6.84M76.24%-1.47M12K-1.48M
Special income (charges) -365.10%-6.84M-57,075.00%-6.84M--0--0----76.24%-1.47M100.19%12K--0---1.48M----
-Less：Restructuring and merger&acquisition 7,367.09%5.74M467.78%5.74M--0--0-----102.41%-79K-147.61%-1.56M--0--1.48M----
-Write off -29.24%1.1M-----------------46.73%1.55M----------------
Income before tax 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Income tax
Net income 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Net income continuous Operations 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Minority interest income
Net income attributable to the parent company 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.08%-56.03M28.05%-14.55M44.73%-11.23M36.40%-13.7M23.56%-16.56M17.80%-83.74M37.33%-20.22M12.08%-20.31M11.36%-21.55M2.44%-21.66M
Basic earnings per share 33.33%-7.6633.67%-1.9944.96%-1.5336.82%-1.8723.83%-2.2718.16%-11.4932.43%-312.58%-2.7812.94%-2.963.87%-2.98
Diluted earnings per share 33.33%-7.6633.67%-1.9944.96%-1.5336.82%-1.8723.83%-2.2718.16%-11.4932.43%-312.58%-2.7812.94%-2.963.87%-2.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -